Skip to main content


Fig. 6 | Cardiovascular Diabetology

Fig. 6

From: SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice

Fig. 6

Representative images of liver sections stained with hematoxylin–eosin showing patches of vacuolated hepatocytes. Liver section from an untreated ob/ob−/− mouse with highly vacuolated hepatocytes and a high steatosis score (a). Liver section from a treated ob/ob−/− mouse with reduced steatosis score (b). The scale bar equals 200 µm in each figure

Back to article page